Outpatient Oncology Infusion Market (By Product: Infusion Pumps, Intravenous Sets, IV Cannulas, Needleless Connectors; By Application: Lung Cancer, Liver Cancer, Breast Cancer, Prostate Cancer; By Therapy: Chemotherapy, Targeted Therapy, Immunotherapy, Hormonal Therapy; By Mode: Intramuscular (IM), Intravenous (IV), Subcutaneous) - Global Industry Analysis, Size, Share, Growth, Trends, Regional Outlook, and Forecast 2024-2033
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology (Premium Insights)
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Outpatient Oncology Infusion Market
5.1. COVID-19 Landscape: Outpatient Oncology Infusion Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Outpatient Oncology Infusion Market, By Product
8.1. Outpatient Oncology Infusion Market, by Product, 2024-2033
8.1.1. Infusion Pumps
8.1.1.1. Market Revenue and Forecast (2021-2033)
8.1.2. Intravenous Sets
8.1.2.1. Market Revenue and Forecast (2021-2033)
8.1.3. IV Cannulas
8.1.3.1. Market Revenue and Forecast (2021-2033)
8.1.4. Needleless Connectors
8.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 9. Global Outpatient Oncology Infusion Market, By Application
9.1. Outpatient Oncology Infusion Market, by Application, 2024-2033
9.1.1. Lung Cancer
9.1.1.1. Market Revenue and Forecast (2021-2033)
9.1.2. Liver Cancer
9.1.2.1. Market Revenue and Forecast (2021-2033)
9.1.3. Breast Cancer
9.1.3.1. Market Revenue and Forecast (2021-2033)
9.1.4. Prostate Cancer
9.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 10. Global Outpatient Oncology Infusion Market, By Therapy
10.1. Outpatient Oncology Infusion Market, by Therapy, 2024-2033
10.1.1. Chemotherapy
10.1.1.1. Market Revenue and Forecast (2021-2033)
10.1.2. Targeted Therapy
10.1.2.1. Market Revenue and Forecast (2021-2033)
10.1.3. Immunotherapy
10.1.3.1. Market Revenue and Forecast (2021-2033)
10.1.4. Hormonal Therapy
10.1.4.1. Market Revenue and Forecast (2021-2033)
Chapter 11. Global Outpatient Oncology Infusion Market, By Mode
11.1. Outpatient Oncology Infusion Market, by Mode, 2024-2033
11.1.1. Intramuscular (IM)
11.1.1.1. Market Revenue and Forecast (2021-2033)
11.1.2. Intravenous (IV)
11.1.2.1. Market Revenue and Forecast (2021-2033)
11.1.3. Subcutaneous
11.1.3.1. Market Revenue and Forecast (2021-2033)
Chapter 12. Global Outpatient Oncology Infusion Market, Regional Estimates and Trend Forecast
12.1. North America
12.1.1. Market Revenue and Forecast, by Product (2021-2033)
12.1.2. Market Revenue and Forecast, by Application (2021-2033)
12.1.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.1.4. Market Revenue and Forecast, by Mode (2021-2033)
12.1.5. U.S.
12.1.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.1.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.1.5.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.1.5.4. Market Revenue and Forecast, by Mode (2021-2033)
12.1.6. Rest of North America
12.1.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.1.6.2. Market Revenue and Forecast, by Application (2021-2033)
12.1.6.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.1.6.4. Market Revenue and Forecast, by Mode (2021-2033)
12.2. Europe
12.2.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.2. Market Revenue and Forecast, by Application (2021-2033)
12.2.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.2.4. Market Revenue and Forecast, by Mode (2021-2033)
12.2.5. UK
12.2.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.2.5.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.2.5.4. Market Revenue and Forecast, by Mode (2021-2033)
12.2.6. Germany
12.2.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.6.2. Market Revenue and Forecast, by Application (2021-2033)
12.2.6.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.2.6.4. Market Revenue and Forecast, by Mode (2021-2033)
12.2.7. France
12.2.7.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.7.2. Market Revenue and Forecast, by Application (2021-2033)
12.2.7.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.2.7.4. Market Revenue and Forecast, by Mode (2021-2033)
12.2.8. Rest of Europe
12.2.8.1. Market Revenue and Forecast, by Product (2021-2033)
12.2.8.2. Market Revenue and Forecast, by Application (2021-2033)
12.2.8.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.2.8.4. Market Revenue and Forecast, by Mode (2021-2033)
12.3. APAC
12.3.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.2. Market Revenue and Forecast, by Application (2021-2033)
12.3.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.3.4. Market Revenue and Forecast, by Mode (2021-2033)
12.3.5. India
12.3.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.3.5.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.3.5.4. Market Revenue and Forecast, by Mode (2021-2033)
12.3.6. China
12.3.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.6.2. Market Revenue and Forecast, by Application (2021-2033)
12.3.6.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.3.6.4. Market Revenue and Forecast, by Mode (2021-2033)
12.3.7. Japan
12.3.7.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.7.2. Market Revenue and Forecast, by Application (2021-2033)
12.3.7.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.3.7.4. Market Revenue and Forecast, by Mode (2021-2033)
12.3.8. Rest of APAC
12.3.8.1. Market Revenue and Forecast, by Product (2021-2033)
12.3.8.2. Market Revenue and Forecast, by Application (2021-2033)
12.3.8.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.3.8.4. Market Revenue and Forecast, by Mode (2021-2033)
12.4. MEA
12.4.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.2. Market Revenue and Forecast, by Application (2021-2033)
12.4.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.4.4. Market Revenue and Forecast, by Mode (2021-2033)
12.4.5. GCC
12.4.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.4.5.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.4.5.4. Market Revenue and Forecast, by Mode (2021-2033)
12.4.6. North Africa
12.4.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.6.2. Market Revenue and Forecast, by Application (2021-2033)
12.4.6.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.4.6.4. Market Revenue and Forecast, by Mode (2021-2033)
12.4.7. South Africa
12.4.7.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.7.2. Market Revenue and Forecast, by Application (2021-2033)
12.4.7.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.4.7.4. Market Revenue and Forecast, by Mode (2021-2033)
12.4.8. Rest of MEA
12.4.8.1. Market Revenue and Forecast, by Product (2021-2033)
12.4.8.2. Market Revenue and Forecast, by Application (2021-2033)
12.4.8.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.4.8.4. Market Revenue and Forecast, by Mode (2021-2033)
12.5. Latin America
12.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.5.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.5.4. Market Revenue and Forecast, by Mode (2021-2033)
12.5.5. Brazil
12.5.5.1. Market Revenue and Forecast, by Product (2021-2033)
12.5.5.2. Market Revenue and Forecast, by Application (2021-2033)
12.5.5.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.5.5.4. Market Revenue and Forecast, by Mode (2021-2033)
12.5.6. Rest of LATAM
12.5.6.1. Market Revenue and Forecast, by Product (2021-2033)
12.5.6.2. Market Revenue and Forecast, by Application (2021-2033)
12.5.6.3. Market Revenue and Forecast, by Therapy (2021-2033)
12.5.6.4. Market Revenue and Forecast, by Mode (2021-2033)
Chapter 13. Company Profiles
13.1. B. Braun Melsungen AG
13.1.1. Company Overview
13.1.2. Product Offerings
13.1.3. Financial Performance
13.1.4. Recent Initiatives
13.2. Baxter
13.2.1. Company Overview
13.2.2. Product Offerings
13.2.3. Financial Performance
13.2.4. Recent Initiatives
13.3. Becton
13.3.1. Company Overview
13.3.2. Product Offerings
13.3.3. Financial Performance
13.3.4. Recent Initiatives
13.4. Dickinson and Company
13.4.1. Company Overview
13.4.2. Product Offerings
13.4.3. Financial Performance
13.4.4. Recent Initiatives
13.5. Fresenius Kabi
13.5.1. Company Overview
13.5.2. Product Offerings
13.5.3. Financial Performance
13.5.4. Recent Initiatives
13.6. ICU Medical, Inc
13.6.1. Company Overview
13.6.2. Product Offerings
13.6.3. Financial Performance
13.6.4. Recent Initiatives
13.7. IRadimed Corporation
13.7.1. Company Overview
13.7.2. Product Offerings
13.7.3. Financial Performance
13.7.4. Recent Initiatives
13.8. Nipro Corporation
13.8.1. Company Overview
13.8.2. Product Offerings
13.8.3. Financial Performance
13.8.4. Recent Initiatives
13.9. Terumo Corporation.
13.9.1. Company Overview
13.9.2. Product Offerings
13.9.3. Financial Performance
13.9.4. Recent Initiatives
13.10. Smith's Medical
13.10.1. Company Overview
13.10.2. Product Offerings
13.10.3. Financial Performance
13.10.4. Recent Initiatives
Chapter 14. Research Methodology
14.1. Primary Research
14.2. Secondary Research
14.3. Assumptions
Chapter 15. Appendix
15.1. About Us
15.2. Glossary of Terms
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
Report Description
Get a Sample